Biogen (BIIB) Approves $5B Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Wall St ends lower for the day and week as chip selloff broadens
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
March 25, 2019 7:49 AM EDTH.C. Wainwright analyst Andrew Fein lowered the price target on Biogen (NASDAQ: BIIB) to $300.00 (from $363.00) while maintaining a Buy rating following the discontinuation of Aducanumab. Despite limited details around the data, Fein thinks this development nevertheless points to the insufficiency in the current... More
